Artwork

Content provided by European Chemicals Agency. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by European Chemicals Agency or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Highlights from the December 2021 Biocidal Products Committee

31:12
 
Share
 

Manage episode 321105611 series 2964225
Content provided by European Chemicals Agency. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by European Chemicals Agency or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

When companies apply to get their biocidal active substances approved or have their biocidal products authorised across the whole EU, individual EU member states check and evaluate the applications.
Then, it is the Biocidal Products Committee that forms an opinion on the evaluation. These opinions are sent to the European Commission which takes the final decision on whether or not to approve the substance for biocidal use.

Listen to Erik van de Plassche, Chair of the Biocidal Products Committee sharing the highlights from the December meeting.
The Committee discussed several active substance applications and two Union authorisations. Our focus in this episode is on the requests that the Committee received from the Commission related to endocrine-disrupting properties of two active substances.
Give us feedback

More

**************
Subscribe to our YouTube channel
Subscribe to our Safer Chemicals Podcast
Subscribe to our news
Follow us on:
*Twitter
*Facebook
*LinkedIn
Visit our website
Disclaimer: Views expressed by interviewees do not necessarily represent the official position of the European Chemicals Agency. All content is up to date at the time of publication.


Hosted by Ausha. See ausha.co/privacy-policy for more information.

  continue reading

52 episodes

Artwork
iconShare
 
Manage episode 321105611 series 2964225
Content provided by European Chemicals Agency. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by European Chemicals Agency or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

When companies apply to get their biocidal active substances approved or have their biocidal products authorised across the whole EU, individual EU member states check and evaluate the applications.
Then, it is the Biocidal Products Committee that forms an opinion on the evaluation. These opinions are sent to the European Commission which takes the final decision on whether or not to approve the substance for biocidal use.

Listen to Erik van de Plassche, Chair of the Biocidal Products Committee sharing the highlights from the December meeting.
The Committee discussed several active substance applications and two Union authorisations. Our focus in this episode is on the requests that the Committee received from the Commission related to endocrine-disrupting properties of two active substances.
Give us feedback

More

**************
Subscribe to our YouTube channel
Subscribe to our Safer Chemicals Podcast
Subscribe to our news
Follow us on:
*Twitter
*Facebook
*LinkedIn
Visit our website
Disclaimer: Views expressed by interviewees do not necessarily represent the official position of the European Chemicals Agency. All content is up to date at the time of publication.


Hosted by Ausha. See ausha.co/privacy-policy for more information.

  continue reading

52 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide